BMO

Analyst updates poured in after Ulta Beauty Inc (NASDAQ: ULTA) reported a fourth-quarter earnings and sales miss, despite comps that were up 8 percent in the quarter. The cosmetics retailer issued weak first-quarter sales guidance and said it expects comps to rise 6-8 percent on the year. ...

Investors are still reeling from this week’s big market sell-off, but BMO Capital Markets says investors shouldn’t hesitate to jump in and buy a pair of bank stocks on the dip. The Analyst BMO analyst Lana Chan upgraded BB&T Corporation (NYSE: BBT) from Market Perform to...

FedEx Corporation (NYSE: FDX) hit a new all-time high of $253.24 after the company handily exceeded Wall Street's expectations in its fiscal second quarter earnings report. Here is a summary of how some of the Street's top analysts responded to the print. Bank Of America: Solid Quarter...

NVIDIA Corporation (NASDAQ: NVDA) can do no wrong in the eyes of the market, after its big Q3 earnings beat sent the stock higher by nearly 6 percent. But with Nvidia shares an incredible 1,000 percent in just three years, the debate rages on among analysts of just how much upside the stock has...

Advanced Micro Devices, Inc. (NASDAQ: AMD) stock tanked more than 12 percent on Wednesday after the company reported third-quarter earnings that clearly disappointed the market. A number of Wall Street analysts weighed in on AMD following the report. Here’s a rundown of what they had to say...

Shares of Costco Wholesale Corporation (NASDAQ: COST) were trading lower by more than 5 percent on Friday after the company's fiscal fourth-quarter earnings report had many investors concerned with a dip in margins. Here is a roundup of what some of Wall Street's most notable analysts are saying...

The mood is mixed on the prospects of Intel Corporation (NASDAQ: INTC) outperforming its forecasts in the coming quarters, even though the chip maker managed to exceed expectations on the strength of firmer PC demand in the just-completed quarter. Charter Equity Research’s Edward Snyder...

Pharmaceutical giants Bristol-Myers Squibb Co (NYSE: BMY) and Merck & Co., Inc. (NYSE: MRK) both release their second quarter earnings reports this week. According to BMO Capital, investors should be buying Merck and selling Bristol-Myers ahead of earnings. Despite Merck being on the verge of...

BMO Capital Markets upgraded shares of Juniper Networks, Inc. (NYSE: JNPR), reasoning that the shares of the company, which have underperformed in the year-to-date period, are ripe for a turnaround. The shares trade at 12 times the firm's 2018 earnings per share estimate for the company, with...

BMO Capital Markets upgraded shares of Visteon Corp (NYSE: VC) following its visit to the company's headquarters last week. The firm clarified that the visit increased the confidence it has in the management's ability to hit its long-term sales and profit targets of $4.7 billion in sales and 14...